All trading involves risk. Ensure you understand those risks before trading.
All trading involves risk. Ensure you understand those risks before trading.

IBM Results What to Expect

Article By: ,  Senior Market Analyst
EPS $3.08 in line with previous year
Revenue $19.18 billion down from $20 billion a year earlier.

Red Hat
This quarter’s focus is squarely on the Red Hat acquisition.

Following consistent declining sales investors will be looking closely for signs that IBM is finally reaping some rewards for its costly acquisition of Red Hat at $34 billion 1 year ago and which completed last week.

IBM is looking for the Red Hat acquisition to revive its cloud business after it lost ground to the likes of Amazon and Alphabet, Google’s parent company, which have dominated the cloud market inventing new ways to provide infrastructure support to large corporations. 

Once a leader in its field, IBM fell behind with the times and over the past 5 years IBM has failed to impress investors. IBM is down 25% over the past 5 years whilst sector peers are up over 40% and the S&P up 62%.

IBM regularly beats estimates on EPS, which means that it would need to do more than that to impress investors this time round. IBM’s Q2 results should give an idea as to whether Red Hat is bringing IBM back into the game, from which it has been absent for a long period. Investors will want to gain a better understanding of what the plan is for Red Hat and how it will be integrated into the business model. Additionally investors will be keen to learn IBM’s position in the cloud market. This was growing at 12%, a sense of how this will evolve will be closely watched for.

Other areas of interest
Also, worth watching will be gross margins, which could bring a positive surprise as could the global technology service revenue.
On the downside, increased macro-economic uncertainty could continue to strike IBM’s emerging market business which failed to perform as expected in the Q1. 

Analysts’ recommendations:
7 buy, 15 hold, 2 sell. 
Average target price $149.16.

IBM Chart
The chart clearly shows a broad descending trend line from its 2017 high. Whilst the stock has been in recovery mode this year, gaining 26% versus the S&P’s 19% gain, the question is whether the rebound can continue. $126.70 has become a key support, whilst a break through $145.35 could indicate a more bullish outlook. 

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.

City Index is a trading name of StoneX Financial Pty Ltd.

The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.

While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.

StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment further CFD investors do not own or have any rights to the underlying assets.

It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.cityindex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.cityindex.com/en-au/terms-and-policies/.

StoneX Financial Pty Ltd, Suite 28.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.

© City Index 2024